News & Events News Discover the latest breakthroughs, stories, and updates from Oncode Institute’s mission to outsmart cancer. Search Category Categorypress newsResearch news Beyond the p values: guide to building your possibly first biotech 12 Apr 2023 The added value and simplicity of data management: the how, the why and what sound data management can bring to your lab 12 Apr 2023 Oncode Investigator Sylvie Noordermeer: ‘Setting up your own research group is both exciting ánd terrifying’ 12 Apr 2023 Oncode shows it can be done in a different way: an interview with Hans Clevers 12 Apr 2023 Exploring vulnerabilities in drug-tolerant colon cancer cells 7 Apr 2023 Oncode Clinical Proof of Concept funded International Leukemia Target Board (iLTB) is now ready for its next steps 31 Mar 2023 New study Sjoerd van der Burg Lab on underlying mechanisms in immunotherapy resistance 17 Mar 2023 Cyclomics starts new research collaboration with Oxford Nanopore Technologies 16 Mar 2023 Hugo Snippert wins 2023 Ammodo Science Award for fundamental research 7 Mar 2023 Oncode Investigators Tineke Lenstra and Jurgen Marteijn receive ENW-M collaborative grant 3 Mar 2023 DNA testing predicts ineffective chemotherapy treatment for colon cancer patients 2 Mar 2023 New EU-funded Project: Fragment-Screen 23 Feb 2023 Unexpected side effect sabotages immunotherapy 22 Feb 2023 Follow-up funding for Oncode Institute to keep cracking the code of cancer 9 Feb 2023 UNCAN.EU survey: identify the next challenges in cancer research! 6 Feb 2023 Hoopvolle trends in 2023 voor kankeronderzoek 3 Feb 2023 Pagination Previous page ‹ … Page 5 Page 6 Page 7 Page 8 Current page 9 Page 10 Page 11 Page 12 Page 13 … Next page ›
The added value and simplicity of data management: the how, the why and what sound data management can bring to your lab 12 Apr 2023
Oncode Investigator Sylvie Noordermeer: ‘Setting up your own research group is both exciting ánd terrifying’ 12 Apr 2023
Oncode Clinical Proof of Concept funded International Leukemia Target Board (iLTB) is now ready for its next steps 31 Mar 2023
